| 发明名称 |
Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes |
| 摘要 |
The present invention regards methods and formulations for the treatment of diabetes and the prevention of autoimmune diabetes. The invention includes the administration of human recombinant GAD65 protein in a pharmaceutically acceptable adjuvant.
|
| 申请公布号 |
US2005209138(A1) |
申请公布日期 |
2005.09.22 |
| 申请号 |
US20040804845 |
申请日期 |
2004.03.19 |
| 申请人 |
DIAMYD THERAPEUTICS AB |
发明人 |
HARRIS ROBERT;ROBERTSON JOHN;ESSEN-MOLLER ANDERS |
| 分类号 |
A61K38/22;A61K38/28;A61K38/51;(IPC1-7):A61K38/22 |
主分类号 |
A61K38/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
